[PDF] from stemcellres.comEJ Gudgin… - Stem Cell Research & Therapy, 2011 - Springer To date, cytogenetic abnormalities have provided most prognostic information, although up to 50% of patients have a normal karyotype [2]. In addition, over the past decade the detection of specific molecular mutations, including mutations in the NPM1 and FLT-3 genes, have ... Related articles - All 4 versions
[PDF] from hindawi.comD Lindquist, D Hellberg, T Tot - Pathology Research …, 2011 - downloads.hindawi.com SAGE-Hindawi Access to Research Pathology Research International Volume 2011, Article ID 860584, 6 pages doi:10.4061/2011/860584 ... Disease Extent ≥4 cm Is a Prognostic Marker of ... D. Lindquist,1, 2 D. Hellberg,2 and T. Tot1 ... 1 Department of Pathology and ... View as HTML
A Rossi, FL Dini, P Faggiano, M Cicoira, S Frattini… - Heart, 2011 - heart.bmj.com Methods and results Patients with HF due to ischaemic and non-ischaemic dilated cardiomyopathy (DCM) were retrospectively recruited. The clinical end point was a composite of all-cause mortality and hospitalisation for worsening HF. FMR was quantitatively determined by measuring ...
G Tang, S Shak, S Paik, SJ Anderson… - Breast cancer research …, 2011 - Springer Abstract The Oncotype DX ® Recurrence Score® (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast cancer. Adjuvant! was developed using SEER registry data and results from the Early Breast Cancer Clinical Trialists' ... Cited by 2 - Related articles - All 4 versions
[HTML] from jcojournal.orgJF Thompson, SJ Soong, CM Balch… - Journal of Clinical …, 2011 - jcojournal.org From the Melanoma Institute Australia; and the University of Sydney, Sydney, New South Wales, Australia; University of Pennsylvania, Philadelphia, PA; Memorial Sloan-Kettering Cancer Center, New York, NY; The University of Texas MD Anderson Cancer Center, Houston, ... Cited by 4 - Related articles - All 5 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
